VascularStrategies is a leading research company based in Plymouth Meeting, PA, specializing in cutting-edge research services for drug development targeting cardiovascular disease. Their comprehensive portfolio includes in vitro and in vivo approaches to investigate the role of lipoprotein function in reversing atherosclerosis through modulation of HDL, Reverse Cholesterol Transport (RCT), and Immune Mediators.
With a team of expert researchers, VascularStrategies offers a complete resource for functional testing and development of therapeutic candidates, making them an ideal partner for those seeking innovative solutions in the field of cardiovascular health.
Generated from the website